Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Insider Trading Galore On Monday, I introduced “The Inside Track” strategy, a trading system triggered by unusual insider buying. Source: Chad McDermott / Shutterstock.com The logic is deceptively si...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If You Can’t Beat Insiders… Why Not Join Them? It was a terrible week for fair-market believers. Last Tuesday, an investigation by the Wall Street Journal revealed more than 130 U.S. federal judges broke t...
Preclinical irreversible small molecule concern, Biomea Fusion, Inc., has lost 40% of its share value since its April 2021 IPO, suffering from a lack of news rather than bad. The company’s covalent bonding compounds offer advantages over reversible oncology therapeutics, which ...
Biomea Fusion to transform to a Clinical Stage Company with First in Human (FIH) Clinical Trial BMF-219 advances as the first clinical stage therapeutic from the company’s deep pipeline of covalent irreversible small molecules BMF-219 is a novel, first-in-class, irreversi...
Completed investigational new drug (“IND”) enabling studies for lead program, BMF-219, an irreversibly binding menin inhibitor. On track to complete IND submission for Phase I/II study of BMF-219 as treatment for patients with menin-dependent acute myeloid leukemia (“...
poba/E+ via Getty Images Biomea Fusion (BMEA) has appointed Franco Valle as Chief Financial Officer and will also assume the role of Principal Financial Officer and Principal Accounting Officer upon joining. Mr. Valle will assume the financial leadership from Sunny Lee. Mr. Va...
REDWOOD CITY, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers,...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The S&P 500 closed the week at another record high, posting its best weekly performance since February, as investors bet that higher infl...
This selection article continues a four-year ad hoc test of published studies that the Russell reconstitution generates excess risk-adjusted returns. In my prior three-year study from 2017, abnormal gains were identified from the annual June rebalancing and some profitable strategies ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 04:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA). Investors who purchased Biomea securities are encouraged to obtain additional information...